Ä¢¹½ÊÓƵAPP
Skip to content
Ä¢¹½ÊÓƵAPP
Companies
Initiatives & Programs
Pioneering Medicines
Pioneering Intelligence
Preemptive Health & Medicine
Flagship Global Engagement
Flagship Fellowship
Pioneering Social Impact
Content
People
About
About Flagship
Process
Join Us
Open Search
Open Menu
Ä¢¹½ÊÓƵAPP
Ä¢¹½ÊÓƵAPP
company
Quotient Therapeutics
All
Abiologics
Alltrna
Ampersand Biomedicines
Apriori Bio
Cellarity
CIBO Technologies
Cystic Fibrosis Foundation
Empress Therapeutics
Ä¢¹½ÊÓƵAPP
Foghorn Therapeutics
Generate:Biomedicines
Harbinger Health
Inari Agriculture
Indigo Agriculture
Invaio Sciences
Korrus
KSQ Therapeutics
Metaphore Biotechnologies
Mirai Bio
Moderna
Montai Therapeutics
Novo Nordisk
Omega Therapeutics
ProFoundâ„¢ Therapeutics
Prologue Medicines
Quotient Therapeutics
Repertoire® Immune Medicines
Ring Therapeutics
Sail Biomedicines
Sana Biotechnology
Seres Therapeutics
Sonata Therapeutics
Tessera Therapeutics
Valo
Vesalius Therapeutics
YourBio Health
year
All
All
2024
2023
domain
All
All
Human Health
Technologies
Sustainability
Ä¢¹½ÊÓƵAPP and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
Quotient Therapeutics
08.28.2024
Ä¢¹½ÊÓƵAPP Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
Quotient Therapeutics
11.21.2023
Loading
Close Search
What are you looking for?
Search
Close Menu
Ä¢¹½ÊÓƵAPP
Companies
Initiatives & Programs
Pioneering Medicines
Pioneering Intelligence
Preemptive Health & Medicine
Flagship Global Engagement
Flagship Fellowship
Pioneering Social Impact
Content
People
About
About Flagship
Process
Join Us
Contact
Careers
Privacy Policy
Terms of Use